Skip to main content

Indigo Agriculture opens European headquarters in Basel

| News

Indigo Agriculture opens European headquarters in Basel

17.09.2019

Indigo Agriculture is expanding to Europe and has opened headquarters in Basel to this end. The U.S. company offers pioneering technologies for the agricultural sector. BaselArea.swiss supported Indigo in relocating to Basel.

How can the quality of wheat be tested? (img: pixabay)

Indigo is opening offices in Basel, from where the company’s European business will be managed, as was reported in a press release. Heading up the Europe segment is Georg Goeres, who was previously responsible for  commercial operations and strategy at Basel agrochemical company Syngenta.

Founded in 2013, the company from Boston develops pioneering technologies for the agricultural sector. These include microbiotechnology for seed treatments, techniques for soil sampling, grain quality testing, remote sensing and analytics as well as a digital marketplace for grain transactions.

Indigo has as its objective to work together with farmers and various interest groups in Europe. The aim is to further optimize the supply chain in farming and offer consumers traceable and nutritious products. In future, Indigo intends to get European farmers on board for Indigo Carbon, a program to accelerate carbon sequestration from agricultural soil. It supplements the Terraton Initiative, a global project to remove one trillion metric tons of carbon dioxide from the Earth’s atmosphere and use it to enrich agricultural soils.

„Indigo is leading the movement towards beneficial agriculture. That makes it the most exciting company I have been a part of in my 25-year career,“ commented Georg Goeres.

BaselArea.swiss supported Indigo in relocating to Basel.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

biGENIUS receives 2 million euros for new cloud product

Software company biGENIUS, based in the Basel Area, has secured financing of 2 million euros. This funding was granted following...
Read More

Opterion Health secures investment of 6.5 million Swiss francs

Opterion Health has raised a total of 6.5 million Swiss francs as part of a financing round. The company, which...
Read More

TOLREMO receives 39 million US dollars in investments

TOLREMO Therapeutics has concluded a series A funding round with 39 million US dollars. The biotech company based in Basel...
Read More

Mazars opens tenth Swiss office in Basel

Mazars is now also present in Basel with a subsidiary as of September 1. This is the tenth Swiss location...
Read More

Medtech in Switzerland – bringing together traditional skills and hightech industry

How the intersection of traditional and novel skillsets in the Jura area is propelling Switzerland into a new era of...
Read More

Fondation Botnar supporting further research into pediatric health

The Basel-based Botnar Research Centre for Child Health has received a further donation of 50 million Swiss francs from the...
Read More

Do you have a question? We'd like to hear from you.